Furmonertinib: First Approval
This article summarizes the milestones in the development of furmonertinib leading to this first approval forEGFR T790M-positive NSCLC.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Drugs & Pharmacology | Lung Cancer | Non-Small Cell Lung Cancer